Product Code: ETC044946 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Malaysia chemotherapy market is expected to reach a CAGR of 6.7% during the forecast period 2020-2026. Factors such as increasing prevalence of cancer, rising awareness regarding early diagnosis and treatment, improvement in reimbursement policies, presence of major drug manufacturers are driving the growth of chemotherapy drugs market in Malaysia. Moreover, government initiatives like free cancer screening programs are also encouraging people to go for preventive health checkups which is anticipated to bolster the chemotherapy drugs market in near future
However, high cost associated with advanced chemotherapies and side effects associated with them may hamper the overall growth of market during the forecast period
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Chemotherapy Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Chemotherapy Market Revenues & Volume, 2020 & 2030F |
3.3 Malaysia Chemotherapy Market - Industry Life Cycle |
3.4 Malaysia Chemotherapy Market - Porter's Five Forces |
3.5 Malaysia Chemotherapy Market Revenues & Volume Share, By Drug Class, 2020 & 2030F |
3.6 Malaysia Chemotherapy Market Revenues & Volume Share, By Indication, 2020 & 2030F |
3.7 Malaysia Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2020 & 2030F |
3.8 Malaysia Chemotherapy Market Revenues & Volume Share, By End-Users, 2020 & 2030F |
4 Malaysia Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Chemotherapy Market Trends |
6 Malaysia Chemotherapy Market, By Types |
6.1 Malaysia Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Chemotherapy Market Revenues & Volume, By Drug Class, 2020-2030F |
6.1.3 Malaysia Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2020-2030F |
6.1.4 Malaysia Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2020-2030F |
6.1.5 Malaysia Chemotherapy Market Revenues & Volume, By Antimetabolites, 2020-2030F |
6.1.6 Malaysia Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2020-2030F |
6.1.7 Malaysia Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2020-2030F |
6.2 Malaysia Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Chemotherapy Market Revenues & Volume, By Lung Cancer, 2020-2030F |
6.2.3 Malaysia Chemotherapy Market Revenues & Volume, By Breast Cancer, 2020-2030F |
6.2.4 Malaysia Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2020-2030F |
6.2.5 Malaysia Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2020-2030F |
6.2.6 Malaysia Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2020-2030F |
6.2.7 Malaysia Chemotherapy Market Revenues & Volume, By Lymphoma, 2020-2030F |
6.2.8 Malaysia Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.2.9 Malaysia Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.3 Malaysia Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Chemotherapy Market Revenues & Volume, By Intravenous, 2020-2030F |
6.3.3 Malaysia Chemotherapy Market Revenues & Volume, By Oral, 2020-2030F |
6.3.4 Malaysia Chemotherapy Market Revenues & Volume, By Subcutaneous, 2020-2030F |
6.3.5 Malaysia Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2020-2030F |
6.3.6 Malaysia Chemotherapy Market Revenues & Volume, By Intravesicular, 2020-2030F |
6.3.7 Malaysia Chemotherapy Market Revenues & Volume, By Topical, 2020-2030F |
6.3.8 Malaysia Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.3.9 Malaysia Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.4 Malaysia Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Chemotherapy Market Revenues & Volume, By Specialty Centers, 2020-2030F |
6.4.3 Malaysia Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2020-2030F |
7 Malaysia Chemotherapy Market Import-Export Trade Statistics |
7.1 Malaysia Chemotherapy Market Export to Major Countries |
7.2 Malaysia Chemotherapy Market Imports from Major Countries |
8 Malaysia Chemotherapy Market Key Performance Indicators |
9 Malaysia Chemotherapy Market - Opportunity Assessment |
9.1 Malaysia Chemotherapy Market Opportunity Assessment, By Drug Class, 2020 & 2030F |
9.2 Malaysia Chemotherapy Market Opportunity Assessment, By Indication, 2020 & 2030F |
9.3 Malaysia Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2020 & 2030F |
9.4 Malaysia Chemotherapy Market Opportunity Assessment, By End-Users, 2020 & 2030F |
10 Malaysia Chemotherapy Market - Competitive Landscape |
10.1 Malaysia Chemotherapy Market Revenue Share, By Companies, 2023 |
10.2 Malaysia Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |